Answers are grounded in this paper and cite their sources.
Background Immune checkpoint blockade has reshaped lung cancer treatment, yet durable benefit remains restricted to a subset of patients. Biomarkers incompletely capture interactions between immune activation and tumor-intrinsic resistance. Integrating immune and epithelial expression programs may help identify response-associated states and candidates for functional investigation. Methods Public bulk transcriptomes were analyzed with format-specific preprocessing, empirical Bayes differential expression, standardized cross-cohort evidence, and gene-set enrichment. Five discovery-informed modules formed an immune-resistance score. Conditional leave-one-out and leave-cohort-out analyses refitted normalization within training data and compared the fixed score with a nested ridge-logistic model. Survival, composition-adjustment, and prioritization sensitivity analyses were performed. Single-cell counts underwent quality control, unsupervised clustering, and patient-level pseudobulk analysis. MAL2 was investigated in A549 and H1299 cells using knockdown, growth, motility, apoptosis, HLA-ABC, cytokine, and PBMC co-culture assays. Results No individual gene met FDR <0.05 in any of the three discovery contrasts. Favorable-response genes were enriched for adaptive immune processes, whereas the unfavorable list showed weaker DNA-replication enrichment. Conditional leave-cohort-out AUCs for the dual-axis score were 0.964, 0.859, and 0.773; performance did not consistently exceed the immune axis. In GSE190266, outcome analysis yielded a cohort-relative AUC of 0.617 with incomplete module coverage. Higher scores were associated with longer PFS in two evaluated cohorts. Quality control retained 91,762 single cells. MAL2 remained epithelial-enriched and ranked third among 58 evaluable candidates, but its patient-level epithelial response contrast and standalone PFS associations were not significant. Knockdown reduced growth and motility-related readouts, increased apoptosis and HLA-ABC expression, and altered cytokine and co-culture activation readouts. Conclusion The immune-resistance framework links cohort-level response patterns to epithelial candidates for functional investigation. MAL2 depletion alters growth and immune-related phenotypes in lung cancer cells, supporting further investigation of its biological role.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: